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Provision of genetic counselling to women with a family history of
breast cancer marks a fairly new development in oncology with
the aim of educating individuals about their risk and encouraging
those at increased risk to engage in health management strategies.
The recent cloning of breast/ovarian cancer susceptibility genes
(BRCA1 and BRCA2) is likely to increase demands on these
clinical services (Miki et al, 1994; Wooster et al, 1995). There is
controversy surrounding genetic counselling for women with a
family history of breast cancer. The benefits of available risk
management options are equivocal (with the exception of
mammography in women aged 50 or over which is known to
reduce deaths from breast cancer). It is not clear whether genetic
counselling helps assuage cancer-related worries or has a benefi-
cial effect on women’s health.
In relation to mental health, women at risk of hereditary breast
cancer may bear a heavy emotional burden (Lloyd et al, 1996) due
to their familial experiences of life-threatening illness, high
bereavement rates and fears of developing breast cancer. Growing
evidence suggests a minority may have prolonged difficulties
which undermine their mental health. A US evaluation of genetic
counselling services indicates that 27% of clinic attenders have
levels of distress consistent with the need for psychological
support (Kash et al, 1992), and results from a population-based
study of high-risk women show that over a third suffer from signif-
icant levels of worry about breast cancer (Lerman et al, 1991).
Psychological responses such as these may undermine the effec-
tiveness of genetic counselling and interfere with uptake of risk
management recommendations.
In addition to the mental health issues it is not clear whether
women understand the genetic information given or can make use
of this in a way that would be beneficial to their mental or physical
health. Current practice in genetic counselling is to convey risk
information numerically, either as a risk of developing the disease
per year, or risk by a certain age. There is some indication that
aspects of genetic information may be poorly understood. Green
(1978) suggested that the qualitative aspect of risk is more impor-
tant than the quantitative and Leonard et al (1972) claim that
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Summary The present study investigated: (1) perception of genetic risk and, (2) the psychological effects of genetic counselling in women
with a family history of breast cancer. Using a prospective design, with assessment pre- and post-genetic counselling at clinics and by postal
follow-up at 1, 6 and 12 months, attenders at four South London genetic clinics were assessed. Participants included 282 women with a family
history of breast cancer. Outcome was measured in terms of mental health, cancer-specific distress and risk perception. High levels of
cancer-specific distress were found pre-genetic counselling, with 28% of participants reporting that they worried about breast cancer
‘frequently or constantly’ and 18% that worry about breast cancer was ‘a severe or definite problem’. Following genetic counselling, levels of
cancer-specific distress were unchanged. General mental health remained unchanged over time (33% psychiatric cases detected pre-genetic
counselling, 27% at 12 months after genetic counselling).
Prior to their genetics consultation, participants showed poor knowledge of their lifetime risk of breast cancer since there was no
association between their perceived lifetime risk (when they were asked to express this as a 1 in x odds ratio) and their actual risk, when the
latter was calculated by the geneticist at the clinic using the CASH model. In contrast, women were more accurate about their risk of breast
cancer pre-genetic counselling when this was assessed in broad categorical terms (i.e. very much lower/very much higher than the average
woman) with a significant association between this rating and the subsequently calculated CASH risk figure (P = 0.001). Genetic counselling
produced a modest shift in the accuracy of perceived lifetime risk, expressed as an odds ratio, which was maintained at 12 months’ follow-up.
A significant minority failed to benefit from genetic counselling; 77 women continued to over-estimate their risk and maintain high levels of
cancer-related worry.
Most clinic attenders were inaccurate in their estimates of the population risk of breast cancer with only 24% able to give the correct figure
prior to genetic counselling and 36% over-estimating this risk. There was some improvement following genetic counselling with 62% able to
give the correct figure, but this information was poorly retained and this figure had dropped to 34% by the 1-year follow-up. The study showed
that women attending for genetic counselling are worried about breast cancer, with 34% indicating that they had initiated the referral to the
genetic clinic themselves. This anxiety is not alleviated by genetic counselling, although women reported that it was less of a problem at
follow-up. Women who continue to over-estimate their risk and worry about breast cancer are likely to go on seeking unnecessary screening
if they are not reassured.
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Hospital, Downs Road, Sutton, Surrey SM2 5PT, UKpeople having genetic counselling ‘are bad at probabilistic
reasoning and find quantitative risk estimates difficult to under-
stand’. If cancer family clinics are to provide a useful service it
would be important to ensure that people understand, and can use,
the risk information and the advice given. Lack of understanding
may impact negatively on their ability to use this information
when making decisions about the future management of their
health and may affect their mental health if cancer-related worries
are increased through some misunderstanding of the information.
The present study set out to examine these issues prospectively in
a series of women with a family history of breast cancer attending
four South London Cancer Family Clinics for genetic counselling.
The study provides data on clinic attenders’ risk perception, general
psychological morbidity and cancer-specific worry.
METHODS
Participants
A consecutive series of 303 female first-time genetic clinic atten-
ders was invited to participate. Accrual took place over 18 months,
at four South London genetic counselling centres [Royal Marsden
NHS Trust Hospital (two separate clinics), Mayday University
Hospital and St Georges’ Hospital], and local ethical committees
approved the study. Inclusion criteria were: a family history of
breast cancer, never clinically affected by cancer, no known
serious mental illness, age 18 years and over, and able to complete
a questionnaire.
Procedure
Assessment was by self-administered questionnaires given at the
genetic clinic immediately pre- and post-genetic consultation and
by postal survey at 1, 6 and 12 months’ follow-up.
Outcome measures
Questionnaires were selected for validity, reliability and prior
application to this population.
Mental health
General Health Questionnaire Goldberg and Williams (1988)
(pre-genetic counselling, 1, 6, and 12 months, follow-up). A brief,
12-item screening instrument assessing psychiatric disorder in non-
psychiatric populations and previously used with medical patients.
State-trait anxiety inventory Spielberger (1983) (pre- and
post-genetic counselling). State version only, to monitor levels of
anxiety at the clinic.
Cancer-specific distress
Cancer Anxiety and Helplessness Scale Described by
Kash (1992) (pre-genetic counselling, 1, 6 and 12 months’ follow-
up). This measures women’s general cancer anxiety and feelings
of helplessness in relation to cancer and cancer treatment.
Impact of Event Scale Horowitz et al (1979) (pre-genetic
counselling and 12 months’ follow-up). Originally developed to
determine levels of distress in response to a specific traumatic
event. A modified version of this questionnaire, which has previ-
ously been used to gather information on cancer-specific distress
in high-risk and general population women was included to assess
psychological response, with specific reference to thoughts about
risk of breast cancer over the last 7 days (Kash et al, 1992). Indices
are provided on the extent to which the women experience intru-
sive and avoidant thoughts about breast cancer risk.
Worry Scale Derived from Lerman and Schwartz (1993) (pre-
genetic counselling and 12 months’ follow-up). Two items were
selected monitoring frequency of worry about cancer and the
degree to which worry was perceived as a problem.
Perception of risk (pre- and post-genetic counselling, and
12 months)
Items assessed knowledge of: i) own lifetime chances of breast
cancer based on the family history (expressed as a 1 in x odds
ratio), ii) relative risk (chances of developing breast cancer
compared with the average woman, on a 5-point scale, from ‘very
much lower’ to ‘very much higher than average’), iii) breast
cancer incidence in the general population (1 in x). These items
were previously developed and validated using other hereditary
breast cancer populations (Lloyd et al, 1996).
Clinic evaluation ‘post-genetic counselling’
Feedback was requested on the consultation and actions advised.
Four-point rating scales assessed perception of clinic effectiveness,
levels of reassurance derived from attendance and the extent to
which information given was perceived to be helpful or worrying.
Other measures
Information was collected prospectively on health behaviours
(these data will be reported fully in a further paper) in relation to
whether women practiced breast self-examination, had read any
leaflets on breast awareness or had had a mammogram. Responses
on these items, assessed at the clinics’ pre-genetic counselling (i.e.
baseline data) are included in the present analysis of factors
predicting cancer worry.
Statistical methods
The  c2 statistic was used to test for evidence of association
between categorical variables. Psychological scores at each time-
point were summarized using mean, standard deviations (SD) or
median, Inter-Quartile Range (IQR) as appropriate, and statistical
tests based on parametric or non-parametric methods as necessary.
Differences from baseline are presented in terms of mean (SD) and
tests based on parametric methods. Differences for ordinal
categorical data items were assessed using the Wilcoxon signed
rank sum statistic. Where required, non-parametric Spearman
Correlation Coefficients were calculated. Stepwise logistic regres-
sion was used to explore predictors of cancer worry. In computing
the subscales for each psychological score on the questionnaires,
all items were required to be present for an overall score to be
calculated. The absence of one or more items from a particular
subscale resulted in that score being deemed missing. All analyses
were carried out using the SPSS release 4.0 package.
RESULTS
Of the 303 participants complying with study entry criteria, ten
eligible women were not approached due to clinic time constraints
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and a further ten declined the invitation to participate, comprising
an overall cohort of 283. One participant was excluded due to
missing baseline data, leaving a total of 282. Participants at each
hospital did not differ significantly on demographic variables (i.e.
social class, marital status and current employment) (Table 1).
Most of the sample (186 participants, 66%) were currently
employed, 204 (72%) were married/cohabiting and 161 (57%)
were white collar/non-manual workers, as determined by the
Office of Population Censuses and Surveys classification system
(HMSO, 1980).
The age range of participants was 19–76 years, median 37 years.
Women who attended the Royal Marsden NHS Trust Hospital
(RMH) clinics were generally of younger age than those attending
Mayday and St George’s Hospitals (Kruskal–Wallis one-way
analysis of variance (ANOVA), P= 0.002). Breast cancer risk was
calculated by the clinical geneticists using the CASH model (Claus
et al, 1991) based on the number of breast cancer cases in first- and
second-degree relatives, the age of family members at disease
onset and age of the woman presenting for genetic counselling.
Women attending the RMH clinics had a higher risk of breast
cancer as determined by the CASH model (P< 0.001; 1 in 5 or
greater). Response rate (i.e. the percentage of the sample who
completed and returned the questionnaires) was 96% (272/282)
immediately post-counselling and, for postal follow-up, was
88% (249/282) at 1 and 6 months and rose to 93% (263/282) at
12 months.
Women were asked how they came to be referred to the clinic;
89/262 (34%) indicated that they had initiated the referral them-
selves. Of these, 55 had approached their General Practitioner
(GP) asking specifically for information about genetic risk and 34
had approached their GP requesting direct access to screening on
the basis of their family history. However, the majority of women
(66%) were referred as the result of recommendation by a GP or
hospital doctor or nurse. Other sources of referral included the well
woman/family planning clinics, research channels and attending
the clinic via a relative’s appointment. No differences in mental
health status were detected between the referral groups on any of
the mental health measures used.
Mental health
Using a cut-off of 3 points or more on the General Health
Questionnaire (GHQ) to determine psychiatric caseness, a
threshold previously applied to general practice samples on the
basis that it achieves a balance between sensitivity and specificity
(May, 1992), one-third of participants had notable levels of
distress. A comparison of GHQ scores indicated no statistically
significant change in general mental health at each follow-up
compared to the pre-genetic counselling level (Table 2). Neither
were there any statistically significant changes in levels of cancer-
specific distress as measured by the Cancer Anxiety and
Helplessness or the Impact of Event Scales.
Follow-up assessment revealed that 35/268 (13%) of the sample
had received some psychological intervention during the 12
months since attending the genetic clinic. Of these, 19 (7%) had
received psychotropic medication, ten (4%) had engaged in
psychological counselling and six (2%) had received both forms of
intervention.
Levels of state anxiety (Spielberger measure) pre-genetic coun-
selling (mean 38.7, SD 10.5) were at a similar level to those
reported in healthy women attending for breast screening (Morris
and Greer, 1982). There was a significant downward shift in
state anxiety immediately post-genetic counselling (mean 35.2,
SD 10.8, P< 0.001).
Prior to genetic counselling, over a quarter (28%) of the sample
stated that they worried about developing breast cancer ‘frequently
or constantly’ and 18% felt that their breast cancer-related worry
was a ‘definite or severe problem’ (Table 3). At 1-year follow-up,
breast cancer worry remained at a similarly high level (23%), but
there was a reduction (12%) in the extent to which this worry was
perceived to be a problem (P= 0.01).
Table 1Demographics by hospital clinic
RMH RMH Mayday St George’s Total
London Sutton
n= 42 (%) n = 45 (%) n = 74 (%) n = 121 (%) n = 282 (%)
Marital status
Married/cohabiting 29 (69) 35 (78) 58 (78) 82 (68) 204 (72)
Single 8 (19) 5 (11) 8 (11) 26 (21) 47 (17)
Divorced/separated/widowed 5 (12) 5 (11) 8 (11) 13 (11) 31 (11)
Currently employed
Yes 30 (71) 29 (64) 46 (62) 81 (67) 186 (66)
No 12 (29) 16 (35) 28 (38) 40 (33) 96 (34)
Social class
I 6 (14) 6 (13) 7  (9) 8(7) 27 (10)
II 14 (33) 13 (29) 23 (31) 36 (30) 86 (30)
IIIN 9 (21) 3  (7) 13 (18) 23 (19) 48 (17)
IIIM 6 (14) 14 (31) 21 (28) 29 (24) 70 (25)
IV 2 (5) 1 (2) 2 (3) 5 (4) 10 (4)
V 1(2) 1 (2) 2 (3) 2 (2) 6(2)
Unclassified 4 (10) 7 (16) 6  (8) 18 (15) 35 (12)
Median age (range) 32 (22–55) 34 (19–61) 41 (28–59) 39 (22–76) 37 (19–76)
aRisk < 1 in 5 33 (79) 32 (73) 27 (39) 39 (33) 131 (48)
aHigh risk relative to general population.Impact of genetic counselling in breast cancer 871
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Risk perception
Table 4 indicates that the correct figure (expressed as an odds
ratio) for lifetime risk was reported by only 25 (9%) women pre-
genetic counselling but this rose to 84 (31%) reporting a correct
odds ratio immediately post-genetic counselling. However, by 1
year the number reporting their risk correctly had dropped to 44
(17%). The correlation between women’s perceived lifetime risk
(i.e. reported as an odds ratio) assessed pre-genetic counselling,
and the CASH risk figures (also an odds ratio) calculated by the
geneticist at the clinic, was not significant (rs = 0.12, P = 0.09),
suggesting that women had poor prior knowledge of their numer-
ical chances of breast cancer when asked to express this in terms of
an odds ratio. Following genetic counselling this association
strengthened (post-counselling, rs = 0.60, P < 0.001) and was
maintained at 12 months, but at a lower level (rx = 0.30 P < 0.001).
Ratings of lifetime risk (CASH) and relative risk were associated
modestly pre-counselling and strengthened at follow-up (pre: rs=-
0.19, p = 0.002; post: rs = -0.50 P < 0.001; 12 months; rs = 0.40, P
< 0.001). Figure 1 shows the proportions of women who over-,
under-, or correctly estimated their lifetime risk at each time point.
In this analysis perceived over- and under-estimation of risk was
defined as any response greater or less than the stated CASH risk
figure, respectively. This appears to show some overall improve-
ment post counselling, with a fall off in improvement at 1 year.
However, the pattern of individual changes from baseline is inter-
esting. One hundred and three (57%) of the 182 women who were
able to give an estimate of personal risk at each time point
remained unchanged in their risk perception, 38 (21%) were previ-
ously incorrect but at 12 months gave the right figure. However,
18 (10%) who were correct pre-counselling later provided an inac-
curate risk estimate at 12 months. The remaining 11% moved
between over- and under-estimating or ‘don’t know’. Of the 126
who over-estimated their lifetime risk pre-genetic counselling and
who also responded at 1 year, 77 (61%) continued to overestimate.
Although those who over-estimated their risk were no different in
terms of general mental health (GHQ) from those who estimated
correctly, or underestimated, their risk they reported significantly
higher cancer-specific distress pre-genetic counselling and at 12
months’ follow-up (P < 0.001 for both avoidance and intrusion
subscales of the Impact of Event Scale at each time point). A
greater proportion of them worried ‘frequently’ or ‘constantly’
about breast cancer at the 12-month follow-up; 43% persistent
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Table 3 Breast cancer worry
Frequency (%) P-valuea
Baseline (n = 282) 12 months (n = 257)
How often do you worry
about breast cancer?
Not at all 26 (9.2) 27 (10.5)
Occasionally 177 (62.8) 170 (66.3)
Frequently 61 (21.6) 49 (19.0) P = 0.09
Constantly 18 (6.4) 11 (4.3)
How much of a problem
is breast cancer worry?
Not at all 81 (28.7) 87 (33.7)
Somewhat 150 (53.2) 140 (54.7)
Definitely 41 (14.5) 23 (8.9) P = 0.01
Severe problem 10 (3.5) 7 (2.7)
aWilcoxon signed rank.872 M Watson et al
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over-estimators versus 22% others (P = 0.002). These results indi-
cate that a substantial minority of women with specific worries
about cancer remain fixed in their own over-estimation of risk and
their worry about breast cancer. Those individuals who under-esti-
mated their risk prior to genetic counselling did not show
increased breast cancer worry once informed of their CASH risk.
There were no differences on the Cancer Anxiety and Helplessness
Scale according to whether correct or incorrect cancer risk esti-
mates were given by the women. When women were asked, pre-
genetic counselling, to rate their risk of breast cancer relative to the
average woman, the majority 151/279 (54%) felt their chances
were ‘somewhat higher than average’, and this perception
remained unchanged with time (post-counselling 144/266 (54%);
12 months 132/255 (52%)). Perceived risk relative to the average
woman was significantly negatively correlated with the geneti-
cists’ calculated risk figure both before and after clinic attendance,
i.e. a high perceived relative risk was correlated with a high CASH
risk figure (pre-genetic counselling; r = -0.21, P < 0.001; post-
genetic counselling: r = -0.43, P < K 0.01; 12 months:, r = -0.31, P
< 0.001). Pre-counselling, 55% (143/260) perceived their relative
risk correctly; this increased slightly to 63% (154/250) post-coun-
selling and 61% (145/249) at 1 year, but not significantly so (P <
0.10 in each case). At 12 months women perceiving their risk to be
very much higher than average were significantly more likely to
report intrusive thoughts about risk of breast cancer (P = 0.01).
Evaluation of women’s estimates of breast cancer incidence in
the general population indicated they were largely inaccurate pre-
genetic counselling; only 68/282 (24%) gave the correct 1 in 12
figure and 101 (36%) over-estimated. In contrast, 167/269 (62%)
gave the correct 1 in 12 figure immediately post-counselling but
this dropped to 87/258 (34%) correct at 12 months. Women’s own
perceived risk, given as an odds ratio, was significantly correlated
with their general population estimate at each time point (P <
0.001 in each case) suggesting that even if these figures were inac-
curate they tended to relate to each other. However, a comparison
between estimates of general population and own risk (odds ratio)
showed that women who got the general population figure correct
pre-counselling were not more likely to get their own risk correct
than those who gave an inaccurate population risk figure.
In summary, specific figures about risk, provided within the
genetic consultation, tend not to be remembered by these women.
Following genetic counselling a significant minority of women
either continue to incorrectly estimate risk or shift their risk esti-
mate in an inaccurate direction. Continual over-estimators may be
worrying unnecessarily and excessively about breast cancer risk
and under-estimators appear undisturbed by the information that
their risk is greater than they thought. Specific defence mecha-
nisms in the latter women may limit their intake of threatening
information. Under-estimators were not significantly different
from the rest of the sample in terms of their scores for intrusive and
avoidant thoughts about breast cancer risk (as measured on the
Impact of Events Scale) when this was assessed pre-counselling.
However, at 12 months’ follow-up their scores were significantly
lower than the rest of the sample on each of these scales (avoid-
ance P = 0.02; intrusion P = 0.006) indicating that in the long-term
they are less likely to report having intrusive thoughts about breast
cancer risk.
Table 4 Estimation of personal risk
Post-counselling
Over-estimate Correct Under-estimate Don’t Know Missing Total
Baseline
Response
Over-estimate 67 40 20 4 7 138
Correct 4 13 8 0 0 25
Under-estimate 12 17 16 0 3 48
Don’t know 12 14 21 6 4 57
Missing 1 0 0 1 12 14
Total 96 84 65 26 11 282
12 months
Over-estimate Correct Under-estimate Don’t Know Missing Total
Baseline
Response
Over-estimate 77 21 22 6 12 138
Correct 8 6 10 0 1 25
Under-estimate 9 9 20 5 5 48
Don’t know 14 8 16 10 9 57
Missing 0 0 0 2 12 14
Total 108 44 68 39 23 282
Pre-counselling
Post-counselling
12 Months
Over-estimators Under-estimators Correct Don't know
Estimation of lifetime chance
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Figure 1 Risk perception (odds ratio)Predictors of cancer worry
Age, perceived risk, actual risk (CASH figure), practice of breast
self-examination, having had a mammogram, and having read
leaflets on breast awareness were used in the modelling procedures
as potential predictors of cancer worry at baseline (categorized as
not at all/occasionally = 0, frequently/constantly = 1). Baseline
Impact of Event Scale and state anxiety scores were not included
as they are so highly correlated with cancer worry. Both at baseline
and at 1 year the only variable seen to have a significant predictive
effect was perceived risk – i.e. it is how women perceive their risk
that predicts cancer worry rather than actual risk. Those who either
under-estimated or correctly perceived their risk were less likely to
worry frequently or constantly about cancer than those who over-
estimated (under-estimators’ odds ratio (OR) = 0.3, 95% confi-
dence interval (CI) = 0.1, 1.0; correct estimators’ OR = 0.5, 95%
CI = 0.2, 1.0, P = 0.02 (trend) pre-counselling; under-estimators’
OR = 0.4, 95% CI =0.2, 1.0; correct estimators’ OR = 0.2, 95% CI
= 0.1, 0.5, P < 0.01 (trend) at 1 year).
Comparable results are obtained when using women’s ratings of
risk relative to the average woman as their perceived risk. Further
models using how much cancer worry is perceived to be a problem
as the outcome variable also gave similar results.
Clinic evaluation
Attitude toward the clinical service was generally favourable. The
majority 252/272 (92%) reported that the clinical had been
‘moderately’ or ‘extremely’ effective and when asked how reas-
suring they felt the consultation had been, 80% indicated that it
was ‘moderately’ or ‘extremely’ reassuring, and only a small
minority (5%), that it was ‘not at all reassuring’. Twenty per cent
of women felt the consultation was moderately or extremely
worrying but the majority (93%) perceived the clinic as ‘moder-
ately or extremely’ helpful.
DISCUSSION
Evidence from this prospective study of genetic clinic attenders
indicates that there are high levels of cancer-related worry that
compare unfavourably to previously gathered data on general
population risk samples (Lloyd et al, 1996). The finding that
genetic counselling fails to alleviate this cancer-specific distress in
a substantial minority of women is contrary to previous US find-
ings (Kash et al, 1992), reporting a reduction in cancer anxiety
several months post-genetic counselling. However, a single
genetic counselling consultation may not be sufficient to shift
these worries in some women and it might be unreasonable to
expect otherwise. General levels of psychological morbidity
(GHQ) remain unaffected by genetic counselling and are consis-
tent with those previously reported elsewhere in the literature
(Watson et al, 1998).
In relation to risk perception and worry about cancer, the data
show that women who consistently over-estimate their breast
cancer risk are most vulnerable to cancer-specific worry. These
women represent a group that can be targeted by clinicians for
psychological support. Such women may constitute a drain on
breast screening services by requesting unnecessary mammograms
and clinical examinations. Psychological support intended to help
alleviate their worries may be more appropriate than breast
surveillance given that the majority of these women are too young
to enter the UK national mammographic screening programme. A
notable finding, in line with results reported by Evans et al (1994),
is that there is a group of women who underestimate their risk and
when given a higher risk estimate by the clinical geneticist do not
show any immediate increase in cancer-related worry. The most
likely explanation is that their perception of risk is unaltered by the
genetic consultation, therefore worry is not triggered because they
continue to underestimate their risk. These constitute an important
group for further investigation. It would be important to know the
impact of risk under-estimation on subsequent level of uptake of
methods for managing their increased risk of breast cancer.
It seems reasonable to assume that women would tend not to be
aware of specific odds ratio risk figures prior to genetic coun-
selling, given that they would be unlikely to consider their risk in
these statistical terms. However, genetic counselling should bring
some change in the tendency for women to under- or over-estimate
their risk since an aim of the consultation is to correct their esti-
mates of risk where necessary. The service produced some imme-
diate improvement in women’s knowledge of their risk figure (a
correct odds ratio being quoted by 31% post-counselling compared
to 9% pre-counselling), but by 1 year follow-up the number of
women giving the correct figure had dropped back to 17%. This
suggests that specific numerical genetic risk information is less
salient to these women than their own risk beliefs, which were not
shifted significantly by the genetic consultation; 57% providing a
risk estimate pre-counselling remained unchanged in their risk
perception. However, the majority were generally in the right
‘ballpark’ for risk with their more general perceptions relative to
the average woman; 61% were correct in this risk estimate at the
12-month follow-up even though they were poor at giving specific
numerical details. This is in contrast with our previous finding
(Lloyd et al, 1996) where no association was found between
CASH calculation and women’s perception of their risk relative to
the general population. However, we previously used a 3-point
rating scale of relative risk which may have been too crude to
distinguish these differences in risk perception.
Women attending the clinic were largely inaccurate in their
reporting of the incidence of breast cancer in the general popula-
tion with only a small proportion (24%) able to give the correct 1
in 12 statistic. In relation to informing women, through genetic
counselling, about the general population risk of breast cancer,
participants were better able to give the correct figure immediately
post-counselling but this information was not retained and had
returned to approximately the same level as pre-counselling 1 year
later.
The impact of increasing numbers of women developing breast
cancer in the general population over the last 3 decades and the
attention the media pays to it may play some role in some of this
worry. Many women will now have the experience of having
family members with breast cancer and will wish to know whether
there is a genetic predisposition. Only a minority may have a
familial predisposition to breast cancer and need to be referred to
specialist genetic services.
Clinical implications
Genetic counselling produced some limited improvement in
women’s understanding of their specific numerical risk of breast
cancer. Many had a general view of their risk relative to the
average woman which was accurate. Of more concern is the
substantial minority who did not benefit from genetic counselling
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because they continued to over-estimate their risk and their worry
about developing breast cancer was unrelieved. A further small
group of women who under-estimated their risk may have failed to
benefit in terms of future management of their health because they
continued to under-estimate risk following the consultation.
Resources may need to be available to provide psychological
support where genetic risk counselling fails to alleviate high levels
of cancer-specific distress and future investigation should be
directed towards examining the value of integrating this into the
service offered. This may require some broadening in the training
of genetic counsellors and associates to provide them with addi-
tional psychological skills, along with integrating mental health
professionals into the genetic teams in a liaison capacity. The
majority of women participating in the investigation attended prior
to the availability of genetic tests for the BRCA1 and BRCA2
cancer predisposition genes. Since genetic testing is already
underway and may raise cancer-related distress in gene carriers
(Watson et al, 1996) the investigation of efficacious methods of
appropriate psychological support is becoming more pressing.
This study highlights some problems in the provision of cancer
genetic counselling. Some women continue to believe they are at
high risk despite being told otherwise and point to a number of
‘worried well’ getting drawn into the system. Many of these women
could probably be managed by general practitioners at the primary
care level rather than within specialist genetic services. Overall,
there is a need to develop better ways of imparting information so
that women understand their risk and how to manage it. A clear
programme of how to deal with genetic risk from the primary care
level through to tertiary services needs to be developed.
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